Inactive Instrument

Company Olainfarm AS Nasdaq Riga

OLF1R

LV0000100501

Pharmaceuticals

End-of-day quote Nasdaq Riga
- ^LVL	-

06/12/21	AS "AB CITY" completed the acquisition of an additional 49.19% stake in AS Olainfarm from a group of shareholders for €64.2 million.	CI
12/11/21	Olainfarm Board OKs AB City's Mandatory Share Buyback Offer	MT

Business description: Olainfarm AS

Olainfarm AS is a Latvia-based company engaged in the pharmaceutical sector. The Company is active in the production of basic pharmaceutical products and pharmaceutical preparations. The Company's activities include numerous finished forms of medicaments with effects, which include cardiological, neurologic, diuretic, spasmologic and antiallergic drug preparations, medicaments treating the digestive system, antibiotics and food supplements, as well as various active chemical ingredients and raw chemical materials. Its products include Amlodipine, Clonazepam, Euphillin, Furosemide, Furagin, Midolat, Protionol and Gripoflex, among others. The Company operates through its subsidiaries which includes Reinolds SIA, Ozols JDR SIA, Olainfarm energija SIA, Ilmas Aptiekas SIA and Veritas-Farm, among others. In addition, the Company has 33 pharmacies, located in Riga, Vidzeme, Kurzeme and Latgale. In May 2013, it acquired a 47.5% shares in pharmaceutical manufacturer SIA Silvanols.

Sales by Activity: Olainfarm AS

Fiscal Period: December	2019 (EUR)	2020 (EUR)
Manufacturing of Medicines	86.84M	75.65M
Retail Sale	25.67M	26.82M
Wholesale	17.55M	17.27M
Other Segments	12.67M	10.46M
Compression Products	12.45M	8.41M
Unallocated and Eliminated	-17.97M	-16.45M

See all business segments

Geographical breakdown of sales: Olainfarm AS

Fiscal Period: December	2019 (EUR)	2020 (EUR)
Latvia	38.8M	39.18M
Russia	44.08M	28.02M
Belarus	15.16M	15.26M
Central Asia	11.15M	11.56M
Ukraine	10.71M	11.46M
EU Countries	10.62M	9.5M
Other Countries	4.6M	4.75M
Caucasus Countries	2.1M	2.44M

See all geographic segments

Executive Committee: Olainfarm AS

Manager	Title	Age	Since
Juris Hmelnickis CEO	Chief Executive Officer	46	31/12/2025
Janis Leimanis DFI	Director of Finance/CFO	56	-
Mikhail Skomorokhov CTO	Chief Tech/Sci/R&D Officer	-	31/12/2009
Vladimirs Krusinskis CTO	Chief Tech/Sci/R&D Officer	47	11/06/2017
Mihails Raizbergs CTO	Chief Tech/Sci/R&D Officer	-	31/12/2005

See OLAINFARM AS governance

Composition of the Board of Directors: Olainfarm AS

Director	Title	Age	Since
Andrejs Leibovics BRD	Director/Board Member	63	18/06/2021
Janis Buks CHM	Chairman	-	31/08/2022
Roberts Tavjevs BRD	Director/Board Member	-	-
Vadims Telica BRD	Director/Board Member	63	-
Sergejs Kornijenko BRD	Director/Board Member	-	-

Composition of the Board of Directors

Company details: Olainfarm AS

Olainfarm AS

Rupnicu iela 5

LV-2114, Olaine

+371 67 013 708

http://www.olpha.eu/

Generic Pharmaceuticals

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SUN PHARMACEUTICAL INDUSTRIES LTD.	-0.36%	-1.73%	+15.64%	+66.76%	47.74B
OTSUKA HOLDINGS CO., LTD.	-3.21%	+1.37%	+52.36%	+125.75%	41.7B
CIPLA LIMITED	-0.83%	-1.64%	-10.46%	+15.59%	12.14B
ZYDUS LIFESCIENCES LIMITED	+0.66%	-1.77%	+13.12%	+70.74%	11.55B
KRKA, D. D.	0.00%	0.00%	+30.00%	+147.62%	9.18B
GEDEON RICHTER	-0.39%	+0.62%	+19.93%	+39.54%	7.54B
ONO PHARMACEUTICAL CO., LTD.	-1.35%	+0.74%	+47.03%	-11.93%	7.35B
GLENMARK PHARMACEUTICALS LIMITED	-0.82%	-0.19%	+19.22%	+198.55%	6.88B
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	+2.65%	-3.55%	-31.27%	+24.03%	5.72B
Average	-0.40%	-0.63%	+17.28%	+75.18%	16.64B
Weighted average by Cap.	-1.05%	-0.54%	+24.56%	+83.49%